Literature DB >> 7859593

Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan.

T Kadowaki1, H Yoshinaga.   

Abstract

Follow-up studies of subjects with impaired glucose tolerance in Japan have shown that a higher level of blood glucose is a major predictor of the subsequent development of non-insulin-dependent diabetes mellitus (NIDDM). In addition, subjects with a lower insulin response to glucose show a higher risk for the development of NIDDM. In fact, most of the subjects who later develop diabetes show a lower insulin response to glucose at the initial examination. Moreover, obesity is generally associated with a higher risk of developing NIDDM. We conclude that low insulin secretion forms an important basis and obesity plays a precipitating role among low-insulin responders in the pathogenesis of the majority of NIDDM patients in Japan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859593     DOI: 10.1016/0168-8227(94)90238-0

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.

Authors:  Tsuyoshi Ohkura; Hideki Shiochi; Youhei Fujioka; Keisuke Sumi; Naoya Yamamoto; Kazuhiko Matsuzawa; Shoichiro Izawa; Hiroshi Kinoshita; Hiroko Ohkura; Masahiko Kato; Shin-ichi Taniguchi; Kazuhiro Yamamoto
Journal:  Cardiovasc Diabetol       Date:  2013-01-22       Impact factor: 9.951

2.  Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period.

Authors:  Caroline Reilhac; Julie Dubourg; Carole Thang; Jean-Marie Grouin; Pascale Fouqueray; Hirotaka Watada
Journal:  Diabetes Obes Metab       Date:  2022-02-08       Impact factor: 6.408

3.  The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.

Authors:  Tsuyoshi Ohkura; Kazuoki Inoue; Youhei Fujioka; Risa Nakanishi; Hideki Shiochi; Keisuke Sumi; Naoya Yamamoto; Kazuhiko Matsuzawa; Shoichiro Izawa; Hiroko Ohkura; Masahiko Kato; Kazuhiro Yamamoto; Shin-ichi Taniguchi
Journal:  BMC Res Notes       Date:  2013-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.